Breaking News
FONT-SIZE Plus   Neg
Share SHARE

Universal Entertainment's Okada Files Counterclaims Against Wynn Resorts

RELATED NEWS
Trade WYNN now with 

Universal Entertainment Corp., headed by Japanese billionaire Kazuo Okada, and its unit Aruze USA Inc. have filed a counterclaim against Wynn Resorts Ltd (WYNN: Quote) and its CEO Steve Wynn to prevent redemption of Wynn Resorts shares owned by Aruze USA at a 30 percent discount.

Responding to the counterclaim, Wynn resorts said that, "Despite its enormous length and scurrilous allegations, the Okada response fails to contain any meaningful denial of the facts detailed in the Freeh Report or Gov. Miller's conference call on Feb. 21, 2012."

Kazuo Okada is the largest shareholder in Wynn Resorts with a 20 percent stake. He was ousted as a director after he was claimed to be unsuitable to continue in the board. Wynn Resorts redeemed Okada's 20 percent stake after an internal investigation revealed that Okada had violated U.S. anti-corruption laws.

In the court filing on Monday, Okada sought permanent injunction, relief and multiple claims for damages against Steve Wynn, a member of the board.

In the counterclaim filed at District Court for Nevada, Okada said that no redemption of shares has occurred and that there is no legal basis for it. He also denied the board's finding that he is "unsuitable" to continue as a member.

The counterclaim states that Steve Wynn has run Wynn Resorts as a personal fiefdom, fielding its Board with friends and doling out huge sums to key staff so that he can control the company. It also charged Steve Wynn of indulging in fraud and defamation.

The counterclaim also said the report by Freeh Sporkin & Sullivan LLP, a law firm hired by Wynn Resorts to investigate Okada, is just a ruse to redeem shares at heavy discount.

Okada said that while Wynn's compliance committee and an investigative report have pointed the finger at Okada's Philippines project, they have not focused on Wynn's own operations in Macau.

Ties between Okada and Steve Wynn soured after Okada filed a writ in January asking to see financial documents relating to a $135 million company donation to the University of Macau.

Wynn Resorts last February said a detailed investigation had uncovered violations of U.S. anti-corruption laws by Kazuo Okada and companies related to him. Wynn said its board asked Okada to resign as director and that it had redeemed Okada's 20 percent stake.

Wynn Resorts filed a lawsuit against Okada, Aruze USA, Inc. and Universal Entertainment Corporation in Nevada District Court, Clark County for breach of fiduciary duty and related offenses.

Pursuant to the finding of "unsuitability", the Board had redeemed Aruze USA Inc.'s 24 million Wynn Resorts' shares, at "fair value", which amounted to a 20 percent stake. Wynn had issued a 10-year $1.9 billion promissory note in redemption of the shares.

WYNN is trading at $125.55, up $4.48 or 3.70%, on a volume of 1.7 million shares on the Nasdaq.

Register
To receive FREE breaking news email alerts for Wynn Resorts Ltd. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy. FCA US, until recently known as Chrysler, said Friday it is recalling 257,000 Dodge Ram pickups. The auto maker says the rear axle pinion nut on certain model year 2005 Dodge Ram 1500 trucks may loosen due to an undersized spline on the pinion gear. If the pinion nut loosens, the rear axle may... This medical device company has a very impressive track record of growing business over the past decade. increasing sales from $490.2 million in 2004 to $1.72 billion this year. The Silicone Hydrogel daily disposable lens portfolio constitutes a major avenue for growth.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.